Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 0 | |
Outperform | 2 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 2 analysts offering 12 month price targets for Eton Pharmaceuticals Inc have a median target of 13.00, with a high estimate of 15.00 and a low estimate of 11.00. The median estimate represents a 20.93% increase from the last price of 10.75.
High | 39.5% | 15.00 |
Med | 20.9% | 13.00 |
Low | 2.3% | 11.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 17, 2025.
Average growth rate | -194.44% |
Average growth rate | -49.06% |
More ▼
Revenue history & estimates in USD
Average growth rate | +10.17% |
Average growth rate | +13,957.45% |
More ▼